• 로봇학회논문지
• /
• 제4권1호
• /
• pp.62-67
• /
• 2009

For diagnoses of digestive organs, capsule endoscopes are widely used and offer valuable information without patient's discomfort. A general capsule endoscope which consists of image sensing module, telemetry module and battery is able to move along gastro-intestinal tracts passively only through peristaltic waves. Thus, it is likely to have some limitations for doctor to acquire images from the desired organs and to diagnose them effectively. As solutions to these problems, a locomotive function of capsule endoscopes has being developed. We have proposed a capsule-type microrobot with synchronized multiple legs. However, the proposed capsular microrobot also has some limitations, such as low speed in advancement, inconvenience to controlling the microrobot, lack of an image module, and deficiency in a steering module. In this paper, we will describe the limitations of the locomotive microrobot and propose solutions to the drawbacks. The solutions are applied to the capsular microrobot and evaluated by in-vitro tests. Based on the experimental results, we conclude that the proposed solutions are effective and appropriate for the locomotive microrobot to explore inside intestinal tracts.

• Journal of Pharmaceutical Investigation
• /
• 제37권3호
• /
• pp.197-203
• /
• 2007

A bioequivalence study of $Dilast^{TM}$ Capsule (Chong Kun Dang Pharma. Co., Ltd.) to $Ketas^{(R)}$ Capsule (Han Dok Pharma. Co., Ltd.) was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty eight healthy male Korean volunteers received each medicine at the ibudilast dose of 20 mg in a $2{\times}2$ crossover study. There was one week wash-out period between the doses. Plasma concentrations of ibudilast were monitored by a liquid chromatography-tandem mass spectrometry (LC-MS/MS) for over a period of 36 hours after drug administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 36 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t\;and\;C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for $Dilast^{TM}$ $Capsule/Ketas^{(R)}$ Capsule were $log0.93{\sim}log1.06$ and $log0.93{\sim}log1.11$, respectively. These values were within the acceptable bioequivalence intervals of $log0.80{\sim}log1.25$. Thus, our study demonstrated the bioequivalence of $Dilast^{TM}$ Capsule and $Ketas^{(R)}$ Capsule with respect to the rate and extent of absorption.

• 한국미생물·생명공학회지
• /
• 제45권2호
• /
• pp.162-167
• /
• 2017

본 연구에서는 동시당화발효공정으로 바이오에탄올을 생산하기 위하여 바이오캡슐 형성을 시도하였다. 다수의 당화곰팡이 균주들과 발효 효모 균주들이 먼저 탐색되었다. Aspergillus sp. BCNU 6200, Penicillium sp. BCNU 6201 및 P. chrysogenum KACC 44363이 ${\alpha}$-amylase와 glucoamylase와 같은 당화 효소를 우수하게 생산하는 균주이었으며, Saccharomyces cerevisiae IFO-M-07이 조사된 균주 중에서 가장 에탄올 생산능이 높았다. 다음으로 pellet 형성 및 바이오 캡슐 형성을 위한 최적 조건을 평가하였다. 모든 조사된 곰팡이 모두 pellet을 형성하였으며, 바이오캡슐의 최적조건은 $28^{\circ}C$, 120 rpm이었다. 최종적으로 형성된 바이오캡슐을 이용하여 동시당화발효를 수행하여, Aspergillus sp. BCNU 6200의 바이오캡슐(Aspergillus sp. BCNU 6200 + S. cerevisiae IFO-M-07)이 10일간 발효시 $30^{\circ}C$, 120 rpm에서 3.9%의 에탄올을 생산함을 확인하였다. 본 실험 결과는 동시 당화발효 공정으로 바이오에탄올을 생산하는데 있어서 바이오캡슐을 활용함에 관한 유용한 정보를 제공하고 있다.

• Journal of Pharmaceutical Investigation
• /
• 제37권4호
• /
• pp.255-261
• /
• 2007

A bioequivalence study of $Nimegen^{TM}$ soft capsule (Medica Korea Pharma. Co., Ltd.) to $RoAccutane^{(R)}$ soft capsule (Roche Korea Ind. Co., Ltd.) was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Thirty healthy male Korean volunteers received each medicine at the isotretinoin dose of 60 mg in a $2{\times}2$ crossover study. There was one week wash-out period between the doses. Plasma concentrations of isotretinoin were monitored by a high performance liquid chromatography (HPLC) for over a period of 48 hours after drug administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 48 hr) was calculated by the linear trapezoidal rule method. $C_{MAX}$ (maximum plasma drug concentration) and $T_{MAX}$ (time to reach $C_{MAX}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t\;and\;C_{MAX}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{MAX}$ ratio for $Nimegen^{TM}/RoAccutane^{(R)}$ were $log0.860{\sim}log0.98\;and\;log0.85{\sim}log1.00$, respectively. These values were within the acceptable bioequivalence intervals of $log0.80{\sim}log1.25$. Thus, our study demonstrated the bioequivalence of $Nimegen^{TM}\;and\;RoAccutane^{(R)}$ with respect to the rate and extent of absorption.

• 한국통신학회논문지
• /
• 제34권12B호
• /
• pp.1524-1534
• /
• 2009

최근 경구약물캡슐에 무선통신수단인 RFID태그기술이 접목되어 이를 이용한 진단 및 모니터링 기술이 세계적으로 급속히 진화하고 있다. 이에 소형이고 저 전력을 소비하며 안전한 RFID태그장착 캡슐에 대한 국내연구개발이 절실한 시점이다. 이 논문은 캡슐통신에 적합한 무선주파수 적합 기술, 생체 내에서 분해 가능한 캡슐 및 RFID 태그 안테나 설계 및 구성기술분야를 대상으로 최신 특허 및 기술, 연구개발정보를 도출하고 구현과제를 분석 제시하는데 중점을 둔다. 논문은 서론, 기술개요, 연구개발 동향, 특허동향, 시장동향, 결론 및 제언으로 구성된다

• 한국통신학회논문지
• /
• 제37권4C호
• /
• pp.329-337
• /
• 2012

캡슐 내시경은 인체 내부의 소화기관 병변을 조사할 수 있는 캡슐 모양의 전자장치로서 인체 내에 케이블을 삽입하는 기존 푸시 타입(push-type)내시경과는 달리 환자에게 공포와 고통을 주지 않는 시술로 인식되고 있어, 최근 환자와 의사 모두에게 큰 관심을 끌고 있다. 이 기술은 바이오 기술(BT), 정보통신 기술(IT), 나노 기술(NT) 등의 성숙과 융합으로 2000년에 들어와 처음으로 가능하게 되었으며, LED를 포함한 광학계와 이미지 센서, 통신 모듈, 파워 모듈 등으로 구성되어 있다. 캡슐 내시경은 첨단 기술의 총체로 유비쿼터스 시대에 다양한 기술 분야의 핵심 기술을 필요로 한다. 따라서 본 논문에서는 캡슐 내시경의 구성에 관해 소개하고, 현재 데이터 전송을 위해 사용되고 있는 대표적인 RF 무선 통신 방식 및 인체 통신 시스템 방식에 대해 비교하였다. 아울러 현재 상용된 캡슐 내시경의 사양을 비교 분석하고, 미래의 캡슐 내시경의 진화 방향과 기술적 도전 과제를 제시하였다.

• 대한기계학회논문집A
• /
• 제30권1호
• /
• pp.84-89
• /
• 2006

A wireless capsule endoscope has been developed to replace the conventional endoscope. However, the commercialized capsule endoscope moves passively by peristaltic waves, which has some limitations for doctors to diagnose more thoroughly and actively. In order to solve this problem, a locomotive mechanism is proposed for wireless capsule endoscopes. Based on the tests of various actuators, a piezo actuator is selected as a micro actuator for capsule endoscope. In general, piezo actuators are known to have limited displacement with high voltage supply. In order to overcome the limitation of common piezo actuator, the impact based piezo actuator, is developed to realize long stroke up 11mm. By using the impact based piezo actuator, a prototype of an earthworm-like locomotive mechanism was developed. In addition, the proposed locomotive mechanism has engraved clamps mimicked the claw of an insect. The earthworm-like locomotive mechanism has 15 mm in diameter and 30mm under retraction stage and 41 mm under elongation stage in total length. Hollow space is allocated to comprise essential endoscope components such as a camera, a communication module, bio sensors, and a battery. For the feasibility test of proposed locomotive mechanism, a series of experiments were carried out including in-vitro tests. Based on results of the experiments, we conclude that the proposed locomotive mechanism is effective to be used for micro capsule endoscopes.

• 대한기계학회논문집A
• /
• 제27권11호
• /
• pp.1849-1855
• /
• 2003

Newly commercialized wireless capsule endoscope has many advantages compared to conventional push-type endoscopes. However, it is moved by the peristaltic waves. Therefore, it can not diagnose desired zones actively. In this paper, a locomotive mechanism for wireless capsule endoscope is proposed to increase the efficiency of endoscopy. We designed and fabricated a prototype using SMA springs and bio-mimetic clamping device. The hollow space in the prototype is allocated for further system integration of a camera module, a RF module and a battery. And the sequential control scheme is employed to improve the efficiency of its locomotion. To validate the performance of the locomotive mechanism, experiments on a silicone rubber pad and in vitro tests are carried out. The results of the experiments indicate that proposed mechanism is effective in harsh environments such as digestive organs of a human.

• Journal of Pharmaceutical Investigation
• /
• 제34권4호
• /
• pp.311-317
• /
• 2004

A bioequivalence study of $Gomcillin^{TM}$ capsules (DAEWOONG Pharmaceutical Co., Korea) to $Famoxin^{TM}$ capsules (Dong Wha Pharm. Ind. Co., Korea) was conducted according to the guideline of Korea Food and Drug Administration (KFDA). Twenty four healthy male Korean volunteers received each medicine at the amoxicillin dose of 500 mg in a $2{\times}2$ crossover study. There was a one-week wash out period between the doses. Plasma concentrations of amoxicillin were monitored by a high-performance liquid chromatography for over a period of 8 hours after the administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 8 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for $Gomcillin^{TM}/Famoxin^{TM}$ were $log0.91\;{\sim}\;log1.03$ and $;log0.93\;{\sim}\;log1.10$, respectively. These values were within the acceptable bioequivalence intervals of $log0.80\;{\sim}\;log1.25$. Thus, our study demonstrated the bioequivalence of $Gomcillin^{TM}$ and $Famoxin^{TM}$ with respect to the rate and extent of absorption.

• 한국축산식품학회지
• /
• 제22권2호
• /
• pp.172-178
• /
• 2002

우유 중에는 여러 종류의 생리활성물질과 우리 몸에 꼭 필요한 비타민이 매우 소량 함유되어 있어, 그 강화를 목적으로 유가공 산업의 발전과 더불어 다양한 비타민 강화우유가 소개되고 있다. 이에 본 연구에서는 가공 처리 및 비타민 강화 방법에 따른 비타민류의 손실율을 조사하였다. 실험 결과, UHT 처리 후에 비타민 C는 60~70% 가까운 손실율을 보였으며, 비교적 열에 안정하다고 알려진 지용성 비타민인 비타민 D$_3$와 비타민 E도 30~40%의 손실율을 보여 주었다. 이에 반해 비타민을 캡슐 형태로 강화하였을 경우에는 수용성 비타민의 손실율은 상대적으로 매우 낮음을 알 수 있었다. 이는 캡슬에 의해 열뿐 아니라 산소, 빛 등이 효과적으로 차단되어 비타민의 손실이 최소화된 것이라 생각된다. 따라서 열처리에 의한 시유 및 강화우유 중의 비타민의 손실을 최소화하기 위해서는 우유의 살균 온도 및 시간, 강화제 첨가 방법 등에 대한 지속적인 연구가 이루어져야 할 것으로 사료된다.